Category Archives: BioUtah News
First Patient Enrolled in Merit Medical’s MOTION Study
First Patient Enrolled in Merit Medical’s MOTION Study
bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance
bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance
ENPICOM and Carterra Advance Antibody Screening by Integrating Biophysical Characterization and Repertoire Sequencing Analysis
By allowing Carterra’s superior epitope, binding affinity, and kinetic information to occupy the same view as sequence information, the IGX Platform enables faster, better decision-making in therapeutic discovery.
National Registry Names Intermountain Health’s Transplant Program as Nation’s Top Program for Successfully Matching Donated Kidneys to Patients
National Registry Names Intermountain Health’s Transplant Program as Nation’s Top Program for Successfully Matching Donated Kidneys to Patients
Merit Medical Announces Process for Chief Executive Officer Succession Planning
Merit Medical Announces Process for Chief Executive Officer Succession Planning
Spectrum Solutions Names Bill Phillips as New Chief Executive Officer
Spectrum Solutions Names Bill Phillips as New Chief Executive Officer
MasterControl Solutions Inc., Expands in Salt Lake County
$40 million capex, 155 jobs, Project Orange
Halia Therapeutics Dosed its First Patient in Phase 2a Clinical Trial of HT-6184, a First-in-Class NLRP3-Inhibitor, for the Treatment of Lower-Risk Myelodysplastic Syndromes
LEHI, Utah /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced the dosing of the first patient in Phase 2a clinical trial evaluating its lead candidate, HT-6184, for the treatment of lower-risk myelodysplastic syndromes (LR-MDS). HT-6184 is a selective and orally bioavailable first-in-class […]
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
BD MiniDraw™ Capillary Blood Collection System Enables Lab-Quality Blood Testing from Less Invasive Method than Venous Collection in More Convenient Locations
Halia Therapeutics co-founder David J. Bearss Featured in Utah Business
Utah Business recently featured Halia Therapeutics co-founder David Bearss in their Founder Series
RxCell Announces $4.6M Investment from DMR Global Venture and Regenosis, Plans for Second Raise of $15M for IND Testing in Q4 2023
SINGAPORE–(BUSINESS WIRE)–RxCell, a pioneering biotech company focusing on cellular therapeutics for age-related diseases, today proudly announces a $4,600,000 investment commitment from DMR Global Venture LLC and Regenosis. Building on the strength of collaboration with National University of Singapore, this fresh investment accentuates RxCell’s resolute drive to revolutionize age-related disease treatment. “We’re thrilled to align with […]
Culmination Bio Raises $10M From Amgen Ventures and Merck Global Health Innovation Fund to Bring Longitudinal Health Data to Biopharma
Culmination Bio has over 40 years of biospecimen data and counting, paired with clinical data from patient EHRs, making recruitment for pharmaceutical research almost instantaneous. St. George, Utah — (November 30, 2023) — Culmination Bio, a company building the largest disease-agnostic patient data intelligence platform, today announced a $10 million investment from Merck Global Health […]
